Renal replacement therapy was introduced in the late 1970s.Burton introduced the term hemofiltration in 1976 and conducted the first multicenter trial to test its accuracy and effectiveness in the same year. Continuous arteriovenous hemofiltration (CAVH) was adopted in 1977 to treat patients with acute renal failure.In addition, CAVH also can preserve hemodynamic stability in critically illpatients.
Kidney disease is now recognized as an endemic problem of public health, affecting more than 850 million people across the globe. The Centers for Disease Control and Prevention (CDC) reported that chronic kidney disease (CKD) affects 15% of the U.S. adults, around 37 million people. Every day, in the U.S., about 13 patients die while waiting for a kidney transplant and renal replacement therapy. The demand for renal replacement therapies has enhanced as its products are helping surgeons to remove solutes in blood and tissue. Apart from this, rising cases of acute kidney injury (AKI), favorable reimbursement policies, and technological advancements in renal replacement therapy systems drive the market growth.
Got questions about your regional growth of
Renal Replacement Therapy Market?
Just drop us a line or call on +1 646 480 7505
The renal replacement therapy market is facing a shortage in the supply of products and consumables used in therapy due to the coronavirus outbreak. The market is estimated to witness revenue loss due to declining inpatient hospital services for renal replacements as most of the beds are occupied by COVID-19 patients. However, Fresenius Medical Care announced plans to assemble a national pool of 150 dialysis machines, which can be deployed to U.S. hospitals.
Renal Replacement Therapy Market: Segmentation
" Crucial Insights The Report Provides:"
* Known and Unknown Adjacencies Influencing the Growth of Market
* Explorable Revenue Sources
* Customer Behaviour Analysis
* Target Partners
* Customized Geographical Data Based on Customers as well as Competitors
* Analysis of Market Size and CAGR between the Forecast PeriodsView Full Report Buy This Report Now